https://bms-540215inhibitor.co....m/bottom-up-p-novo-f
Purpose To define plasma cell-free disease genome chromosomal instabilities (CIN) in patients with liver disease also to evaluate the potential of CIN as minimally unpleasant biomarkers for major liver cancer (PLC) diagnoses. Experimental design We obtained 196 plasma samples from 172 people in 2 cohorts, a discovery cohort of surgery ineligible PLC patients and a validation cohort of hepatectomy clients with pathological disease confirmations. All samples were exposed t